About Rozanolixizumab In-house
Class: | Monoclonal antibody (IgG1)
Use: | Treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody positive
Adult dose: | Initial dose of 1 mg/kg administered subcutaneously, followed by 1 mg/kg every 2 weeks; may be adjusted based on clinical response
Pediatric dose: | Safety and efficacy not established in pediatric populations
Side effects: | Injection site reactions, headache, nausea, fatigue, and increased risk of infections
C
Drug Class
Monoclonal antibody (IgG1)
Uses & Indications
Treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody positive
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: UCB Pharma S.A., BELGIUM
Package Size
1's Glass Vial ( 2 ml )
Price & Supplier
Price in UAE: AED 43824.00
Dosage Information
Adult Dose
Initial dose of 1 mg/kg administered subcutaneously, followed by 1 mg/kg every 2 weeks; may be adjusted based on clinical response
Pediatric Dose
Safety and efficacy not established in pediatric populations
Side Effects
Injection site reactions, headache, nausea, fatigue, and increased risk of infections
Contraindications & Precautions
Hypersensitivity to rozanolixizumab or any component of the formulation; active infections
Important Warnings
Monitor for signs of infection; may cause infusion-related reactions; caution in patients with a history of malignancy or severe infections; not recommended for use during pregnancy unless clearly needed
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.